Hope for a cure: new drug combo trial targets parasitic skin disease in ethiopia
NCT ID NCT07463040
First seen Mar 24, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tests four new treatment plans for cutaneous leishmaniasis, a parasitic skin disease that causes painful sores. 900 people in Ethiopia will receive either the standard drug or one of the new combinations. The goal is to see which treatment cures all lesions by day 90, with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LEIHMANIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
ALERT Hospital
Addis Ababa, Ethiopia
Contact
Contact Email: •••••@•••••
-
Arba Minch General Hospital
Arba Minch, Ethiopia
Contact Email: •••••@•••••
Contact
-
Boru Meda General Hospital
Boru, Ethiopia
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.